ECRAID-Base Launches European Clinical Research Alliance
Utrecht, Wednesday February 24th – Following the signing of the Grant Agreement by the European Commission (EC), ECRAID-Base has secured funding of 30 million euros and will commence March 1st 2021. ECRAID-Base is the core set of activities for ECRAID (the European Clinical Research Alliance for Infectious Diseases), which aspires to become the first of its kind, pan-European clinical research network for infectious diseases in Europe. Over the five-year duration of ECRAID-Base, ECRAID will evolve into a self-sustaining, not-for-profit organisation conducting clinical research for both public and private sponsors.
ECRAID-Base Annoucement_Press_Release_Final_ (002)Download publication
Related media library items

RECOVER Enrols First Participants in Three COVID-19 Studies
PREPARE Activated to Mode 2 in Response to Novel Coronavirus Cases in Europe
PREPARE PR_Mode2
European Response to Outbreak with Novel Coronavirus in China
Press_Release_Novel_Coronavirus_PREPARE